Comparison of gemcitabine versus the matrix metalloproteinase inhibitor BAY 12-9566 in patients with advanced or metastatic adenocarcinoma of the pancreas: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group (Q44567807)
Jump to navigation
Jump to search
scientific article published in September 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Comparison of gemcitabine versus the matrix metalloproteinase inhibitor BAY 12-9566 in patients with advanced or metastatic adenocarcinoma of the pancreas: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group |
scientific article published in September 2003 |
Statements
1 reference
Comparison of gemcitabine versus the matrix metalloproteinase inhibitor BAY 12-9566 in patients with advanced or metastatic adenocarcinoma of the pancreas: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group (English)
1 reference
1 reference
National Cancer Institute of Canada Clinical Trials Group
1 reference
M J Moore
1 reference
J Hamm
1 reference
J Dancey
1 reference
P D Eisenberg
1 reference
M Dagenais
1 reference
A Fields
1 reference
K Hagan
1 reference
B Greenberg
1 reference
B Colwell
1 reference
D Tu
1 reference
J Ottaway
1 reference
R Humphrey
1 reference
L Seymour
1 reference
1 September 2003
1 reference
1 reference
Identifiers
1 reference